Enzymatica AB (publ) (STO:ENZY)
Sweden · Delayed Price · Currency is SEK 1.900
-0.100 (-5.00%)
At close: Dec 30, 2025
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 461.2 million as of December 31, 2025. Its market cap has increased by 19.41% in one year.
Market Cap
461.20M
Enterprise Value
429.42M
Revenue
52.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.90
Market Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 461.20M, an increase of 323.40%. That is a compound annual growth rate of 10.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 461.20M | 35.28% |
| Dec 30, 2024 | 340.92M | -47.39% |
| Dec 29, 2023 | 647.99M | -12.33% |
| Dec 30, 2022 | 739.16M | -43.36% |
| Dec 30, 2021 | 1.31B | -51.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.70B |
| Getinge AB | 59.59B |
| Sectra AB | 48.36B |
| Camurus AB | 36.74B |
| Medicover AB | 33.29B |
| Asker Healthcare Group AB | 32.33B |
| BioArctic AB | 27.55B |
| Elekta AB | 21.68B |